Axsome Therapeutics (AXSM) News Today $111.29 +0.16 (+0.14%) Closing price 04:00 PM EasternExtended Trading$112.00 +0.70 (+0.63%) As of 06:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock AXSM Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Versor Investments LP Invests $2.29 Million in Axsome Therapeutics, Inc. (NASDAQ:AXSM)August 19 at 7:53 AM | marketbeat.comAxsome Therapeutics, Inc. $AXSM Shares Purchased by Charles Schwab Investment Management Inc.August 19 at 4:00 AM | marketbeat.comInvesco Ltd. Boosts Stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM)August 18 at 4:11 AM | marketbeat.comVanguard Group Inc. Sells 25,537 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM)August 17 at 3:36 AM | marketbeat.comFox Run Management L.L.C. Boosts Stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM)August 16 at 8:45 AM | marketbeat.comNuveen LLC Makes New $48.19 Million Investment in Axsome Therapeutics, Inc. (NASDAQ:AXSM)August 16 at 4:28 AM | marketbeat.comDeutsche Bank AG Sells 25,567 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM)August 16 at 3:39 AM | marketbeat.comInformed Momentum Co LLC Acquires New Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM)August 13, 2025 | marketbeat.comVirtu Financial LLC Acquires New Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM)August 13, 2025 | marketbeat.comAxsome Therapeutics, Inc. (NASDAQ:AXSM) Shares Bought by Connor Clark & Lunn Investment Management Ltd.August 11, 2025 | marketbeat.comXTX Topco Ltd Sells 9,794 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM)August 10, 2025 | marketbeat.comHC Wainwright Issues Negative Forecast for AXSM EarningsAugust 10, 2025 | americanbankingnews.comFY2026 EPS Estimates for AXSM Increased by Cantor FitzgeraldAugust 9, 2025 | marketbeat.comHC Wainwright Issues Pessimistic Estimate for AXSM EarningsAugust 9, 2025 | marketbeat.comAxsome Therapeutics’ Earnings Call Highlights Robust GrowthAugust 8, 2025 | theglobeandmail.comFY2026 EPS Estimates for AXSM Decreased by Cantor FitzgeraldAugust 8, 2025 | marketbeat.comHC Wainwright Brokers Lower Earnings Estimates for AXSMAugust 8, 2025 | marketbeat.comLeerink Partnrs Issues Optimistic Estimate for AXSM EarningsAugust 8, 2025 | marketbeat.comQ3 EPS Estimate for Axsome Therapeutics Raised by AnalystAugust 8, 2025 | americanbankingnews.comQ3 EPS Forecast for Axsome Therapeutics Decreased by AnalystAugust 7, 2025 | marketbeat.comWells Fargo Sticks to Their Buy Rating for Axsome Therapeutics (AXSM)August 7, 2025 | theglobeandmail.comAxsome Therapeutics, Inc. (NASDAQ:AXSM) Q2 2025 Earnings Call TranscriptAugust 6, 2025 | msn.comAxsome Therapeutics (NASDAQ:AXSM) Price Target Raised to $176.00August 6, 2025 | marketbeat.comRoyal Bank Of Canada Issues Positive Forecast for Axsome Therapeutics (NASDAQ:AXSM) Stock PriceAugust 6, 2025 | marketbeat.comWhat is William Blair's Estimate for AXSM FY2027 Earnings?August 6, 2025 | marketbeat.comAxsome Therapeutics Jumps 5% as Q2 Revenue Surpasses ProjectionsAugust 6, 2025 | msn.comAxsome Therapeutics Analysts Increase Their Forecasts After Q2 EarningsAugust 5, 2025 | benzinga.comAxsome Therapeutics (NASDAQ:AXSM) Announces Quarterly Earnings Results, Beats Estimates By $0.12 EPSAugust 5, 2025 | marketbeat.comFederated Hermes Inc. Makes New Investment in Axsome Therapeutics, Inc. (NASDAQ:AXSM)August 5, 2025 | marketbeat.comTD Asset Management Inc Takes Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM)August 5, 2025 | marketbeat.comAxsome Therapeutics, Inc. (AXSM) Q2 2025 Earnings Call TranscriptAugust 4, 2025 | seekingalpha.comAxsome Therapeutics, Inc. 2025 Q2 - Results - Earnings Call PresentationAugust 4, 2025 | seekingalpha.comAxsome Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business UpdateAugust 4, 2025 | globenewswire.comJ. Safra Sarasin Holding AG Purchases Shares of 9,660 Axsome Therapeutics, Inc. (NASDAQ:AXSM)August 4, 2025 | marketbeat.comPrivium Fund Management B.V. Has $6.15 Million Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM)August 3, 2025 | marketbeat.comA Look at Axsome Therapeutics's Upcoming Earnings ReportAugust 1, 2025 | benzinga.comAxsome Therapeutics (AXSM) to Release Earnings on MondayJuly 28, 2025 | marketbeat.comRoyce & Associates LP Reduces Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM)July 28, 2025 | marketbeat.comUniversal Beteiligungs und Servicegesellschaft mbH Makes New Investment in Axsome Therapeutics, Inc. (NASDAQ:AXSM)July 28, 2025 | marketbeat.comCwm LLC Trims Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM)July 28, 2025 | marketbeat.comEnvestnet Asset Management Inc. Sells 10,086 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM)July 28, 2025 | marketbeat.comAxsome Therapeutics, Inc. (NASDAQ:AXSM) Shares Sold by Knights of Columbus Asset Advisors LLCJuly 27, 2025 | marketbeat.comWilliam Blair Issues Positive Forecast for AXSM EarningsJuly 24, 2025 | marketbeat.com2 Top Stocks I Wouldn't Hesitate to Invest $1,000 in Right NowJuly 24, 2025 | fool.comLegato Capital Management LLC Buys New Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM)July 24, 2025 | marketbeat.comY Intercept Hong Kong Ltd Purchases New Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM)July 24, 2025 | marketbeat.comAxsome Therapeutics (NASDAQ:AXSM) Trading Down 5.6% - Here's What HappenedJuly 23, 2025 | marketbeat.comReadystate Asset Management LP Invests $6.95 Million in Axsome Therapeutics, Inc. (NASDAQ:AXSM)July 22, 2025 | marketbeat.comAxsome Therapeutics, Inc. (NASDAQ:AXSM) is Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A.'s 4th Largest PositionJuly 22, 2025 | marketbeat.comAxsome Therapeutics, Inc. (NASDAQ:AXSM) Shares Purchased by New York State Common Retirement FundJuly 22, 2025 | marketbeat.com Get Axsome Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AXSM and its competitors with MarketBeat's FREE daily newsletter. Email Address AXSM Media Mentions By Week AXSM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AXSM News Sentiment▼1.710.47▲Average Medical News Sentiment AXSM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AXSM Articles This Week▼913▲AXSM Articles Average Week Get Axsome Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AXSM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies JAZZ News TEVA News SMMT News GMAB News VTRS News RDY News ASND News MRNA News QGEN News BBIO News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AXSM) was last updated on 8/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Axsome Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Axsome Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access